Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
ENA-78, human recombinant protein
human ENA-78, Epithelial neutrophil-activating protein 78
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | P42830 |
|---|---|
| Calculated MW | 8.0 kDa |
| Gene ID | 6374 |
|---|---|
| Gene Symbol | ENA-78 |
| Other Names | Small inducible cytokine B5, CXCL5, Epithelial-derived neutrophil-activating protein 78, Neutrophil-activating peptide, ENA-78, ENA-78(1-78), chemokine (C-X-C motif) ligand 5, SCYB5, |
| Gene Source | Human |
| Source | E. coli |
| Assay&Purity | SDS-PAGE; ≥98% |
| Assay2&Purity2 | HPLC; ≥98% |
| Recombinant | Yes |
| Results | 50 ng/ ml |
| Target/Specificity | ENA-78 |
| Application Notes | Reconstitute in H₂O to a concentration of 0.1-1 µg/ µl. It is recommended that further dilutions be made into buffer containing carrier protein or medium containing serum. |
| Format | Lyophilized protein |
| Storage | -20°C; Lyophilized with no additives. The protein may appear as a haze or film which is difficult to see at the bottom of the vial. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
ENA-78 (Epithelial Neutrophil Activating Peptide-78) is a recently discovered chemoattractant and activator for neutrophils, belonging to the IL-8 subgroup of the C-X-C family of chemokines. The human ENA-78 is an 8.0 kDa protein containing 74 amino acid residues.
References
Power C.A.,et al.Gene 151:333-334(1994).
Chang M.S.,et al.J. Biol. Chem. 269:25277-25282(1994).
Corbett M.S.,et al.Biochem. Biophys. Res. Commun. 205:612-617(1994).
Zhang C.,et al.Blood 98:610-617(2001).
Amoli M.M.,et al.Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.
Ordering Information
Other Products
Shipping Information
